 , B01AC — Platelet aggregation inhibitors excl. heparin , B01A — ANTITHROMBOTIC AGENTS , B01 — ANTITHROMBOTIC AGENTS , B — BLOOD AND BLOOD FORMING ORGANS , C07FX — Beta blocking agents, other combinations , C07F — BETA BLOCKING AGENTS, OTHER COMBINATIONS , C07 — BETA BLOCKING AGENTS , C — CARDIOVASCULAR SYSTEM , C10BX — HMG CoA reductase inhibitors, other combinations , C10B — LIPID MODIFYING AGENTS, COMBINATIONS , C10 — LIPID MODIFYING AGENTS , C — CARDIOVASCULAR SYSTEM , M01BA — Antiinflammatory/antirheumatic agents in combination with corticosteroids , M01B — ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION , M01 — ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS , M — MUSCULO-SKELETAL SYSTEM , N02BA — Salicylic acid and derivatives , N02B — OTHER ANALGESICS AND ANTIPYRETICS , N02 — ANALGESICS , N — NERVOUS SYSTEM , C10BX — HMG CoA reductase inhibitors, other combinations , C10B — LIPID MODIFYING AGENTS, COMBINATIONS , C10 — LIPID MODIFYING AGENTS , C — CARDIOVASCULAR SYSTEM , B01AC — Platelet aggregation inhibitors excl. heparin , B01A — ANTITHROMBOTIC AGENTS , B01 — ANTITHROMBOTIC AGENTS , B — BLOOD AND BLOOD FORMING ORGANS , N02AJ — Opioids in combination with non-opioid analgesics , N02A — OPIOIDS , N02 — ANALGESICS , N — NERVOUS SYSTEM , N02AJ — Opioids in combination with non-opioid analgesics , N02A — OPIOIDS , N02 — ANALGESICS , N — NERVOUS SYSTEM , N02BA — Salicylic acid and derivatives , N02B — OTHER ANALGESICS AND ANTIPYRETICS , N02 — ANALGESICS , N — NERVOUS SYSTEM , C10BX — HMG CoA reductase inhibitors, other combinations , C10B — LIPID MODIFYING AGENTS, COMBINATIONS , C10 — LIPID MODIFYING AGENTS , C — CARDIOVASCULAR SYSTEM , N02BA — Salicylic acid and derivatives , N02B — OTHER ANALGESICS AND ANTIPYRETICS , N02 — ANALGESICS , N — NERVOUS SYSTEM , A01AD — Other agents for local oral treatment , A01A — STOMATOLOGICAL PREPARATIONS , A01 — STOMATOLOGICAL PREPARATIONS , A — ALIMENTARY TRACT AND METABOLISM , C10BX — HMG CoA reductase inhibitors, other combinations , C10B — LIPID MODIFYING AGENTS, COMBINATIONS , C10 — LIPID MODIFYING AGENTS , C — CARDIOVASCULAR SYSTEM , C07FX — Beta blocking agents, other combinations , C07F — BETA BLOCKING AGENTS, OTHER COMBINATIONS , C07 — BETA BLOCKING AGENTS , C — CARDIOVASCULAR SYSTEM , N02AJ — Opioids in combination with non-opioid analgesics , N02A — OPIOIDS , N02 — ANALGESICS , N — NERVOUS SYSTEM , C10BX — HMG CoA reductase inhibitors, other combinations , C10B — LIPID MODIFYING AGENTS, COMBINATIONS , C10 — LIPID MODIFYING AGENTS , C — CARDIOVASCULAR SYSTEM , C10BX — HMG CoA reductase inhibitors, other combinations , C10B — LIPID MODIFYING AGENTS, COMBINATIONS , C10 — LIPID MODIFYING AGENTS , C — CARDIOVASCULAR SYSTEM , C10BX — HMG CoA reductase inhibitors, other combinations , C10B — LIPID MODIFYING AGENTS, COMBINATIONS , C10 — LIPID MODIFYING AGENTS , C — CARDIOVASCULAR SYSTEM , C07FX — Beta blocking agents, other combinations , C07F — BETA BLOCKING AGENTS, OTHER COMBINATIONS , C07 — BETA BLOCKING AGENTS , C — CARDIOVASCULAR SYSTEM